MARC details
000 -LEADER |
fixed length control field |
05011naaaa2201321uu 4500 |
001 - CONTROL NUMBER |
control field |
https://directory.doabooks.org/handle/20.500.12854/87472 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20220714201755.0 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
books978-3-0365-4420-5 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783036544199 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783036544205 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.3390/books978-3-0365-4420-5 |
Terms of availability |
doi |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
English |
042 ## - AUTHENTICATION CODE |
Authentication code |
dc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
M |
Source |
bicssc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MJ |
Source |
bicssc |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Golubovskaya, Vita |
Relator code |
edt |
9 (RLIN) |
1629406 |
245 10 - TITLE STATEMENT |
Title |
Immunotherapy, Tumor Microenvironment and Survival Signaling |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Basel |
Name of publisher, distributor, etc |
MDPI - Multidisciplinary Digital Publishing Institute |
Date of publication, distribution, etc |
2022 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 electronic resource (376 p.) |
506 0# - RESTRICTIONS ON ACCESS NOTE |
Terms governing access |
Open Access |
Source of term |
star |
Standardized terminology for access restriction |
Unrestricted online access |
520 ## - SUMMARY, ETC. |
Summary, etc |
The book is based on the Cancers journal Special Issue entitled "Immunotherapy, Tumor Microenvironment and Survival Signaling", and focuses on important problems concerning tumors and tumor microenvironment interactions, as well as novel immunotherapies such as CAR-T cell therapy. Immunotherapies have recently shown remarkable results in the treatment of cancer patients. However, there are still many questions that remain to be solved in regards to more effective therapies, such as the tumor heterogeneous profile, tumor microenvironment, and tumor survival epigenetic and genetic pathways, all of which make patients resistant to the presently available treatments for cancer. This book demonstrates different approaches to overcome the challenges faced by immunotherapies due to suppressive tumor microenvironments. This book includes 18 papers that can be divided into three chapters: 1. novel immunotherapies; 2. targeting tumor microenvironment and novel approaches; 3. targeting tumors and tumor microenvironment in different types of cancer. |
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
Terms governing use and reproduction |
Creative Commons |
-- |
https://creativecommons.org/licenses/by/4.0/ |
-- |
cc |
-- |
https://creativecommons.org/licenses/by/4.0/ |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Medicine |
Source of heading or term |
bicssc |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Clinical & internal medicine |
Source of heading or term |
bicssc |
9 (RLIN) |
890883 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Autophagy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
colorectal cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immunotherapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tumor stroma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tumor microenvironment |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immune checkpoint inhibitors |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
chemotherapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tyrosine kinase inhibitors |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
angiogenesis |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
check point inhibitors |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
programmed cell death protein 1 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
programmed cell death 1 ligand 1 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cardiotoxicity |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
lung metastasis |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CAR-T |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hypoxia |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tumor |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
microenvironment |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CD19 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
BCMA |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
melanoma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immune escape |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
antigen loss |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
chimeric antigen receptor |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
electroporation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
lentivirus |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
lentiviral transduction |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
macrophages |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
leukemia cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
lytic peptides |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
targeted therapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
dendritic cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
pathogenesis |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
risk factors |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
breast cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
resistance |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
checkpoint |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
targeted treatment |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
personalized medicine |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
pediatric solid tumors |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
chimeric antigen receptors |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cancer vaccines |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
oncolytic viral therapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immunomodulation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
DCLK1 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tumor stem cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
clonogenicity |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
mitochondria |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
mitochondrial transfer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tunneling nanotubes |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
triple-negative breast cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immune checkpoint inhibitor |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
combination therapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cancer nanomedicine |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tumor antigens |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cancer metabolism |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cancer immunotherapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
nanoparticles |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immunotherapeutic agent |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immunomodulators |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tuft cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cancer stem cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immunotherapies |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
myeloid-derived suppressor cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
regulatory T cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
crosstalk |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tumor immune evasion |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cell-cell contact |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
β2 integrins |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CD18 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CD11 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CAR-T cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CD37 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cell therapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tumor antigen |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
lymphoma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CAR macrophage |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CAR T cell |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
solid tumors |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immunometabolism |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
miRNA |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immunogenic cell death |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
n/a |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Golubovskaya, Vita |
Relator code |
oth |
9 (RLIN) |
1629406 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://mdpi.com/books/pdfview/book/5660">https://mdpi.com/books/pdfview/book/5660</a> |
-- |
0 |
Public note |
DOAB: download the publication |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://directory.doabooks.org/handle/20.500.12854/87472">https://directory.doabooks.org/handle/20.500.12854/87472</a> |
-- |
0 |
Public note |
DOAB: description of the publication |